REQUEST A DEMO
Total
USD $0.00
Search more companies

Solpharma Sp. z o.o. (Poland)

Main Activities: Marketing Research and Public Opinion Polling
Full name: Solpharma Sp. z o.o. Profile Updated: March 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Solpharma Sp. z o.o. is an enterprise located in Poland, with the main office in Elizowka. The enterprise currently operates in the Marketing Research and Public Opinion Polling sector. The enterprise was incorporated on October 09, 2019. In 2024, the company reported a net sales revenue increase of 29.27%. Its’ total assets recorded a negative growth of 41.6%.

Headquarters
Ul. Szafranowa 6
Elizowka; Lubelskie; Postal Code: 21-003

Contact Details: Purchase the Solpharma Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Solpharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Solpharma Sp. z o.o. report to view the information.
Incorporation Date:
October 09, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Solpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
29.27%
Total operating revenue
27.85%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
-41.6%
Total Equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
40.95%
Quick Ratio
0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?